- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
CytRx Corp+ Add to Watchlist
CYTR:US5.2601 USD 0.2201 4.37%
As of 15:46:10 ET on 12/18/2013.
Company Profile for CytRx Corp (CYTR)
CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.
Key Executives for CytRx Corp (CYTR)
|Steven A KriegsmanPresident/CEO||Jean-Yves Caloz "John"CFO/Treasurer|
|Daniel J LevittExec VP/Chief Medical Officer||Scott D GeyerSenior VP:Manufacturing|
|Scott WielandSenior VP:Drug Development||Benjamin S LevinVP:Legal Affairs/Secy/Gen Counsel|
|David J HaenVP:Business Development|